Incidence of type 1, type 2 diabetes increased; rates of increase higher in racial/ethnic minorities.
Researchers conducted a study to compare improvement in symptoms of genitourinary syndrome of menopause between women who underwent fractional vaginal laser therapy and women treated with vaginal estrogen alone.
Researchers sought to better understand the clinical practice patterns of ob-gyn physicians regarding their screening practices and management of depression during menopause.
Eating a poor-quality low-fat or low-carb diet may not positively affect mortality rates and may even cause harm.
The results suggest that the current recommended levels for breastfeeding duration are linked to an additional benefit of reduced risk for early menopause.
Public health screening of 2- to 5-year-olds revealed an islet autoantibody prevalence of 0.31%.
The performance of a European Society of Cardiology algorithm in ruling out acute myocardial infarction without ST-elevation was comparable in patients with and without diabetes mellitus.
Odds of experiencing multimorbidity by age 60 and developing individual chronic conditions increased.
Menopause is linked to unfavorable health effects in women with type 2 diabetes, but older age at menarche may be associated with a decrease in these adverse effects.
N Engl J Med. 2018;379(25):2407-2416.
Metabolic syndrome is associated with poorer sleep in girls with polycystic ovary syndrome and obesity.
Self-esteem improved after 5 years in surgical group, but no improvement seen in overall mood.
Peer-delivered program tied to improvements in quality of life, physical activity, pain.
Researchers performed a systematic review and meta-analysis to summarize and update the evidence regarding the effects of lifestyle intervention, including diet, on cardiometabolic risk among overweight and obese women with PCOS.
Agency releases new estimates of physical inactivity across states and US territories.
Lorcaserin may potentially increase the risk of cancer, according to results from a clinical trial assessing the safety of the weight loss agent.
Low-fat diets tied to lower testosterone, even after controlling for other factors.
Gout incidence rate significantly reduced with SGLT2 inhibitor vs GLP-1 receptor agonist.
Telemedicine instead of office visit did not change outcomes in patients with suboptimal glycemic control.